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Abstract (2011/300 words) 
Background: The United Kingdom Working Party’s (UKWP) criteria were developed to improve 
epidemiological research in atopic dermatitis (AD), but have not been validated in an exclusively adult 
European population.  
Objective: To validate the UKWP criteria for AD in adults. 
Methods: In this cross-sectional study, three independent samples of adult individuals were drawn and 
interviewed: patients with a hospital diagnosis of AD or plaque psoriasis in adulthood, and general 
population controls. Various versions of the UKWP criteria for AD were utilized.  
Results: A total of 3,490 (general population), 3,834 (AD), and 4,016 (psoriasis) adult individuals were 
erolled in the study. The best combination of the UKWP criteria lead to a sensitivity of 0.71 and a specificity 
of 0.96 in the general population. The criteria better captured ‘AD ever’ compared to ‘AD within the past 12 
months’, and had a higher sensitivity in patients with moderate (87.2-97.7%) or severe (95.8-100%) AD at 
the time of interview compared to those who where asymptomatic (12.6-36.8%). The specificity of the 
UKWP criteria was lower when a group of psoriasis patients was used as control groupThe UKWP .criteria 
also captured high proportions of psoriasis patients (19.7-47.7%) when applied in a cohort of unique 
psoriasis patients. 
Conclusions: It remains a challenge to accurately diagnose a history of AD in adulthood since symptoms are 
shared with other skin conditions and AD may have resolved or can be waxing and waning, in turn leading to 
recall bias. The UKWP criteria performed well in the general population for the purpose of determining the 






Atopic dermatitis (AD) is a prevalent inflammatory skin condition of childhood and adulthood..  
The 1980 Hanifin and Rajka (H&R) criteria were developed to better delineate AD patients for clinical and 
investigative studies and avoid misclassification.1 However, some criteria proved to be either unspecific or 
occur very infrequently. Some criteria were predominately derived from clinical features observed in AD 
patients with European ancestry,2 and expectedly, their performance is less good in non-European 
populations.3 To further complicate things, some criteria require invasive diagnostic tests, and several 
clinical features seem to suffer from interobservator variability and be highly dependent on the patients 
gender, age, and AD severity.3-7  
To improve epidemiological research in AD, the United Kingdom Working Party’s (UKWP) Criteria for AD 
were developed in 1994, using the original Hanifin and Rajka criteria as a starting point. The UKWP criteria 
were validated in groups of predominately pediatric patients with AD as well as healthy controls, and 
patients with other inflammatory skin conditions.2, 8, 9 Based on these studies, six features were identified that 
could reliably separate predominately pediatric AD from other inflammatory skin conditions (Table 1). The 
major criterion, itch, was selected as it was considered very sensitive, whereas the minor criteria were 
selected as they were considered to be specific.8  
 
The UKWP refinement of the Hanifin and Rajka criteria were applied in a cross-sectional survey of 695 
British school children aged 3-11 years, and showed a sensitivity of 70%, a specificity of 93%, a positive 
predictive value (PPV) of 47% and a negative predictive value (NPV) of 97% when compared with 
dermatologist examination.10 False positive cases were ascribed to current inactivity of eczema at the time of 
examination. While two validation studies have since examined the performance of the UKWP criteria for 
AD in Asian adults,11, 12 the UKWP criteria for AD have not yet been exclusively validated in a European 













Importantly, different versions of the adapted UKWP criteria gave different associations between AD and 
cardiovascular comorbidities in adults in a general population study.13 Moreover, recent large surveys have 
attempted to determine the prevalence of adult AD, and study its comorbidity, by using adapted UKWP 
criteria. This has spawned growing concerns that the UKWP criteria in their current form cannot be used 
indiscriminantly to study issues such as the co-morbidities of AD in adults 14, 15  
We validated the UKWP criteria for AD in adults from the general population. Because of the higher 
prevalence, and increasing incidence of psoriasis, in adults when compared with children,16 we also included 









MATERIALS AND METHODS 
Sampling of the Danish Skin Cohort 
The prospective Danish Skin Cohort was first established in 2018 to study AD and plaque psoriasis18. 
Briefly, the cohort was generated based on 3 independent samples, respectively, i) 10,000 adults from the 
general population sample randomly drawn from the general Danish population (CPR register) with no 
diagnostic code of psoriasis or AD in the hospital system, ii) 10,000 adult patients with a diagnostic code for 
AD (but not plaque psoriasis), and iii) 10,000 adult patients with a diagnostic code for plaque psoriasis (but 
not AD) randomly drawn from the National Patient Registry.18 The entire Danish adult population, aged 18 
years or older, was eligible for selection. The Danish National Patient Register contains information on all 
diagnoses given predominately by health care providers from public and private hospitals (both inpatient and 
outpatient clinics).19. This register was used to sample the AD and psoriasis populations. Specifically, the 
AD and psoriasis samples consisted of patients that had received at least one dermatologist diagnosis of, 
respectively, AD (International Classification of Diseases [ICD]-10 L20) or plaque psoriasis (ICD-10 L40.0) 
given after their 18th birthday. Both diagnoses have been validated and show very high PPV (97% for 
psoriasis and 92-98% for AD).20, 21 Importantly, all patients with AD who also had a diagnosis of psoriasis 
given by any health care provider in the National Patient Registry were excluded and vice versa. To reduce 
participation bias, study participants were not informed about the scope or content of the research project 
before agreeing to participate. All 30,000 individuals from the three samples were contacted with a written 
invitation. To increase study participation, patients were contacted via phone a total of five times. 
Interviews  
Enrolled adults were interviewed at baseline in a structured manner.22 Disease specific questions related to 
AD and psoriasis were given to participants from all samples. The exact wording used to generate different 
version of the UKWP criteria for AD is shown in Table E1.  
The major UKWP criterion was based on either a ‘history of an itchy skin condition’ or a ‘history of an itchy 








were used in the analysis: i) ‘onset of this condition <2 years’ or ‘onset of this condition in childhood’, ii) 
history of flexural involvement, iii) personal history of asthma or hay fever, iv) ‘history of dry skin all over 
the body’, or ‘history of dry skin all over the body within the past 12 months’, v) ‘visible flexural dermatitis’ 
which was assessed by asking patients about current flexural involvement (cubital fossa or popliteal fossa). 
For details about the original UKWP criteria, the practical manual can be reached online23 and the current 
criteria are shown in Table 1. AD severity was assessed by the Patient-Oriented SCORing Atopic Dermatitis 
(PO-SCORAD)24 for 100% of included subjects. AD severity was then categorized into asymptomatic (PO-
SCORAD=0), mild (PO-SCORAD=0.1-24.9), moderate (PO-SCORAD=25.0-50.0), and severe (PO-
SCORAD>50.0) disease. Psoriasis patients were asked to measure the body surface area (BSA) currently 
affected by psoriasis, which had previously been shown to accurately reflect physician-reported BSA 
scores.25 Psoriasis severity was categorized based on BSA into mild (BSA <3), moderate (BSA 3-10), and 
severe (BSA ≥10). 
To study the performance of the UKWP criteria across we created the following groups: i) general 
population controls (respectively, ‘all controls’, ‘controls who never had AD [either physician diagnosed or 
self-reported]’, and ‘controls who never had AD or psoriasis [either physician diagnosed or self-reported]’), 
ii) patients with dermatologist verified AD (patients that had never received a diagnosis of psoriasis), and iii) 
patients with dermatologist verified plaque psoriasis (patients that had never received a diagnosis of AD). 
Creation of the subgroups was done to allow for possible detection of individuals where the UKWP criteria 
would not perform equally well.  
Statistical analysis  
We examined, respectively, the ‘lifetime’ and ‘12-month’ prevalence of AD by using two different versions 
of the major criterion itch (i.e. ‘a history of itchy skin condition ever’ vs. ‘a history of an itchy skin condition 
within the past 12-months’) and, respectively, 2-3 of 4-5 minor criteria (Table 2 and Table E2). The 
prevalence of AD in adults with a hospital code of AD reflected the sensitivity (selected data are shown in 
Tables 2, 3 and all data are shown in Tables E2-E9). The specificity was calculated by the following 





population and psoriasis samples. To calculate the PPV, we used the following equation PPV= (true 
positive)/(true positive + false positive). To calculate the NPV, we used the following equation NPV= (true 




A total of 3,490 (general population), 3,834 (adults with AD), and 4,016 (adults with psoriasis) individuals 
accepted the invitation and were enrolled. Among, respectively, general population controls, AD patients, 
and psoriasis patients, 55.4%, 69.0% and 55.8% were women. Psoriasis patients were, as expected, older 
than AD patients, e.g. 72.9% of psoriasis patients were 55 years or older compared to 30.7% of AD patients. 
General population controls were more evenly distributed across age groups.  
Table 2 shows the estimated prevalence of AD when using various combinations of the UKWP criteria 2/5 
and 3/5. The sensitivity, specificity, PPV and NPV are detailed in Table 3. Only these data will be discussed 
in this article, but additional results for 2/4 and 3/4 as well as 2/5 or 3/5 minor criteria can be found in the 
Tables E2-E9. Analyses showed essentially the same results as the data presented here.  
Overall, the estimated prevalence (and sensitivity) of AD was slightly lower when a positive response to the 
question about ‘onset of an itchy skin condition’ was restricted to ‘onset before 2 years of age’ rather than 
‘onset during childhood’, and similarly, when ‘a history of dry skin all over the body’ was restricted to 
‘within the past 12 months’ rather than ‘ever’. Similar, studying 2/5 minor criteria gave higher prevalence 
estimates than 3/5 minor criteria. For example, the prevalence of ‘AD ever’ increased from 4.2-7.8% to 13.4-
16.2% in the general population sample when using 3/5 and 2/5 minor criteria, respectively.  
The sensitivity of the UKWP criteria in the general population reached 0.52-0.82 when 2/5 minor criteria 
were used compared to 0.40-0.71 when 3/5 minor criteria (Tables 2 and 3 and Fig. 1). The best combination 
was found for 3 of 5 minor criteria asking about disease onset in childhood and a history of dry skin ‘ever’, 
leading to a sensitivity of 0.71 and a specificity of 0.96 (Table 3). The sensitivity of the UKWP criteria was 
highest when attempting to capture individuals with ‘AD ever’ compared to ‘AD within the past 12 months’. 
The specificity was high for all combinations of the minor criteria (0.89-0.99) in the general population. 
The adapted UKWP criteria that were used to diagnose ‘AD in the past 12 months’ performed well in the 
group of AD patients who did not report any skin problems within the past 12 months, since only 1.9-5.0% 
reported having AD within the past 12 months. The sensitivity of the UKWP criteria when diagnosing ‘AD 
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ever’ was low (12.6-36.8%) when examined in an AD population who reported being asymptomatic at the 
time of interview, but who had at least one previous hospital contact due to AD. The UKWP criteria had a 
high sensitivity when used to diagnose ‘AD ever’ in patients with moderate (87.2-97.7%) or severe (95.8-
100%) disease as assessed by the PO-SCORAD.  
These combinations of the UKWP criteria also captured high proportions of psoriasis patients (19.7-47.7%). 
This tendency can be appreciated graphically in Fig. 2, which shows the proportion of adults with 
dermatologists verified AD and plaque psoriasis, respectively, that fulfilled the UKWP criteria. Similar 
patterns were observed when studying ‘AD within the past 12 months’. 
Fig. 3 shows the percentage of patients with dermatologist-verified plaque psoriasis and AD that met the 
respective major and minor UKWP criteria for AD by disease severity. Most criteria performed very well in 
those with moderate to severe AD as high positive response rates were observed. However, the major 
criterion also lead to very high positive response rates in patients with psoriasis (78.9%-92.3%), and 
generally, there seemed to be no differences in the rate of positive responses among psoriasis patients with 
mild, moderate and severe disease. Accordingly, the PPV was high when using the AD criteria in a group of 





This large interview-based study examined the validity of various versions of the UKWP criteria for AD. 
The best combination of the UKWP criteria led to a sensitivity of 0.71 and a specificity of 0.96 in the general 
population. When compared with an exclusive psoriasis population, the UKWP incorrectly diagnosed a large 
proportion of psoriasis patients as having AD. 
Interpretation 
The UKWP criteria for AD were developed in an attempt to improve diagnostic criteria for this very 
common inflammatory skin condition of childhood. The criteria were validated in a clinical setting where 
most participants were children and where patients with other inflammatory skin conditions also were 
included.2, 8, 9 The criteria were also successfully validated in a survey including British school children,10 but 
proved to be less useful in pediatric South African and Ethiopian populations.26, 27 Notably, an attempt to 
validate the UKWP criteria in Iranian children28 prompted a useful overview of challenges that need to be 
addressed when performing a good validation of a set of criteria29: i) the recommended protocol should be 
strictly followed, ii) exact translation to a different language, if needed, is crucial and require first translation 
to the new language and then translation back to the primary language, iii) the criteria should be tested in the 
setting they were developed for, iv) one needs to ensure that the assessor, as much as possible, is blinded to 
the criteria that are being evaluated, and v) ensure that the assessor has the same clinical skills as the average 
clinician who are expected to use them. While the performance of the UKWP criteria in children is not 
flawless, they are widely accepted to reliably identify pediatric AD. Importantly, few other chronic 
inflammatory skin diseases than eczemas exist in high numbers in children, e.g. psoriasis, in turn increasing 
the accuracy of the criteria. 
To our knowledge, only two validation studies have so far examined the performance of the UKWP criteria 
for AD in adults.11, 12 A Taiwanese study conducted in nursing staff, showed a sensitivity of 42.2%, a 












members at health care centers showed that the sensitivity was 70%, the specificity 90%, the PPV 90.5% and 
the NPV 95.2%. Both studies validated the UKWP criteria in populations where study participants had 
knowledge about health care and diseases, which might have affected the outcome. However, importantly, 
both studies did not examine the validity in a group of individuals with other skin conditions such as 
psoriasis. Indeed, in our study, we included a group of psoriasis patients, since this disorder has become a 
common condition and now affects up to 8% of adult Danes and 11% of Norwegians.30-32 Psoriasis is chronic 
condition characterized by sharply demarcated symmetrical lesions on several body parts, including the 
knees and elbows. However, it is also an itchy condition and some lesions in flexures may be less well 
demarcated. Although psoriasis is different from AD, they are not mutually exclusive diseases.33 Psoriasis 
patients may suffer from respiratory problems due to smoking or overweight, and they even get diagnosed 
with asthma more often than the general population.34 In the light of these clinical characteristics, it is not 
surprising that the UKWP in their survey form, and when used in adults, may incorrectly capture psoriasis 
patients as having AD. Importantly, psoriasis is very uncommon in young children, and when the UKWP 
criteria for AD are used in this age-group, psoriasis is unlikely to have major impacts the accuracy of the 
UKWP criteria., though it has not been examined. However, due to the high psoriasis prevalence in adults, 
this may constitute a genuine problem, particularly for studies of disease co-morbidities where one must be 
certain that index cases really have the disease of interest. A simple way to exclude this problem in future 
studies could be to ask about a personal history of psoriasis. Other relevant groups with skin conditions that 
could ideally have been studied in our survey include stasis dermatitis, lichen planus, non-unspecific 
eczemas and contact eczemas,7 as then when generalized, may also incorrectly be categorized as being AD. 
In fact, there have been previous concerns about the inclusion of periorbital eczema in the ‘visible flexural 
dermatitis criteria’ as this may also occur in allergic contact dermatitis in adults.35, 36 Importantly, the risk of 
misclassification is less of not a concern for the prevalence estimatatione given the high specificity and 

















As per the original UKWP manual instructions, the most suitable form of the criteria need to be applied to 
the appropriate study. For a general population prevalence study, the UKWP criteria provide a fair trade-off 
between sensitivity and specificity, but for a case control study where one has to be sure that the cases are 
genuine, more specific versions are needed and are described in the online manual.37 Highly specific versions 
of the criteria are also needed for studies of disease co-morbidity in order to minimize inclusion of psoriasis 
patients and associated psoriasis co-morbidity. As stated in the original UKWP manual “In countries where 
there is a high prevalence of other skin diseases that could be confused with atopic eczema, such as scabies 
or onchocerciasis, it seems prudent to stipulate that the eruption must lack specific features of that 
dermatosis.”38 Those conducting the examination should be capable of identifying eruptions of other 
common dermatoses, and preferably be dermatologists.  
Collectively, our adult data study indicates that various versions of the UKWP refinement of the Hanifin and 
Rajka criteria may misclassify cases of psoriasis and possibly other skin conditions as AD. Our findings have 
important ramifications for the interpretation of prevalence and comorbidity studies using UKWP criteria in 
adults, and even for surveys using questions based on chronicity and itch to identify AD, since there is a high 
likelihood that other inflammatory skin conditions have been captured besides AD. For example,. since 
psoriasis is strongly associated with obesity, diabetes, and heart disease, this could explain some of the 
positive associations between AD and cardiovascular risk factors found in previous studies.13, 39, 40 Moreover, 
comorbidities that are infrequent in psoriasis patients, but frequent in AD patients, may be underestimated in 
case of misclassification. Future epidemiological comorbidity studies using the UKWP criteria in adult 
populations should therefore be carefully performed to avoid misclassification.  and false high prevalence 
rates. 
Limitations 
This study had several limitations. The participation rate was low, but this is the expected level of such 
studies in Denmark nowadays. We do not expect that the participation rate influenced the interpretation of 
the study since the control groups consisted of AD and psoriasis patients who had their diagnosis given by a 







prevalence of AD in the general adult population. Importantly, individuals were unaware of the specific 
content of the survey when enrolled, thereby limiting the risk of participation bias. Difference in time 
between signs and symptoms of skin disease and questioning may have affected the results given that an 
itchy skin condition is necessary criterion for the UKWP criteria. Using the UKWP criteria in AD and 
psoriasis patient populations is a very stringent and arguably artificial test, e.g. the inclusion of asymptomatic 
AD patients.  
Conclusion
Clinicians and researchers should be cognizant about the important limitations of using the UKWP criteria 
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Table 1 - UKWP criteria for AD in children 
Table 2 – Numbers and percentages of patients meeting the UKWP criteria across populations 
Table 3 - Validity of the UKWP criteria with different control populations 
Figure 1 – Differences in speficitiy of the UKWP criteria when different control populations are used 
Legend: These figures show differences in sensitivity and specificity when the general population and 
patients with psoriasis, respectively, are used as control groups. When the sensitivity is high, the specificity 
is heterogeneous and dependent on the control population, suggesting that misclassification is high. When 
the specificity is high in both control populations, the sensitivity is low. AD, atopic dermatitis; UKWP, 
United Kingdom Working Party 
Figure 2 – Proportion (%) of adults with dermatologists verified atopic dermatitis and plaque 
psoriasis, respectively, that fulfill the UKWP criteria 
Legend: In various combinations, the sensitivity of of the United Kingdom Working Party (UKWP) criteria 
fluctuates considearbly. When most sensitive, the UKWP criteria captures 81.7% of adult patients with 
atopic dermatitis, but at the same time they also capture 47.7% of adult patients with plaque psoriasis. 
Figure 3 – Percentage of patients with dermatologist-verified plaque psoriasis and atopic dermatitis 
meeting the respective UKWP criteria  
